[ad_1] AstraZeneca has announced the positive results of DECLARE (Effect Dapagliflozin on cardiovascular events), a cardiovascular effects test (CVOT) of Poshi (name of the ingredient: Dapagliffrozen). The findings are presented in a …
Read More »Tuzeo significantly reduces the incidence of hypoglycemia during the titration period
[ad_1] In recent years, the use of the next generation of basal insulin has expanded In June of this year, the American Diabetes Association (ADA 2018) introduced Toujeo , an insulin glargine …
Read More »